ER+/HER2+ Metastatic Breast Cancer
2 Vues
• 07/03/23
0
0
Intégrer
administrator
Les abonnés
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires